Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit(®) RL 100 Nanoparticles for Ocular Delivery

Fenofibrate (FE) has been shown to markedly reduce the progression of diabetic retinopathy and age-related macular degeneration in clinical trials and animal models. Owing to the limited aqueous solubility of FE, it may hamper ocular bioavailability and result in low efficiency to treat such disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Khin, Soe Yadanar, Soe, Hay Man Saung Hnin, Chansriniyom, Chaisak, Pornputtapong, Natapol, Asasutjarit, Rathapon, Loftsson, Thorsteinn, Jansook, Phatsawee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370055/
https://www.ncbi.nlm.nih.gov/pubmed/35897940
http://dx.doi.org/10.3390/molecules27154755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370055/
https://www.ncbi.nlm.nih.gov/pubmed/35897940
http://dx.doi.org/10.3390/molecules27154755

Ejemplares similares